Abstract
Introduction
With an aging population, the prevalence of fragility ankle fractures is rising. The surgical management of these injuries is challenging and associated with high rates of complications. The incidence of fragility ankle fractures is currently estimated to be around 150 per 100,000 people annually and is anticipated to rise to around 269 per 100,000 by 2030. The aim of surgery is to restore mobility, preserve function and to prevent complications related to non-weight-bearing and the application of hind foot nail (HFN) seems to provide these advantages. This systematic review aims to investigate the role of HFN in the treatment of fragility ankle fractures. We aim to review the available evidence published on the functional recovery observed in patients following treatment with HFN and the observed complications in the literature.
Materials and Methods
A review of the current literature was conducted to identify recent systematic reviews on the use of HFN in the treatment of fragility ankle fractures. Our electronic search included the following databases; Web of Sciences, Cochrane Database of Systematic Review, MEDLINE, CINHAL, and Academic Search Premier. We also conducted a web search using Google Scholar for sake of completeness. Studies published from the inception of data until September 2019 that assess the effectiveness of HFN in patients with osteoporotic ankle fractures were included. Articles meeting the inclusion criteria were read in full and assessed against the eligibility criteria.
Results
Six case series and one randomized controlled trial included in our review. The total number of patients included was 194, of them, 145 were females and 49 males. The age range of all cases was 37–98 years (mean 76.39 years). Patients' demographic data, follow-up duration, Postoperative weight-bearing status, postoperative complications, mortality and Olerud and Molander score (OMAS) scores have been obtained in details.
Conclusions
The use of HFN have found that it has favorable outcomes regarding early rehabilitation, restoration of function and length of hospital stay. Prospective trials comparing the outcome of patients with fragility ankle fractures treated with HFN vs conventional treatments are warranted, particularly with long periods of follow ups.
